Kaitlyn Arsenault, Chief Financial Officer at Skye Bioscience, Inc. (SKYE), sold 43,396 shares at $5.55 ($217K) on 2024-11-15, disclosed to the SEC on 2024-11-19.
Open-market sale of $217k SKYE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.55 | 190 | $1K | 0.5% |
| 2 | $4.99 | 43,206 | $216K | 99.5% |
| Total | $4.99 avg | 43,396 | $217K | 100% |